What's in Human Genome Sciences Inc.'s pipeline?

Human Genome Sciences Inc. has 5 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 2 in Phase 2, 1 in Phase 1.

Which companies overlap with Human Genome Sciences Inc.'s portfolio?

Top competitors by shared drug class: Bayer, Biogen, Case Comprehensive Cancer Center, Celgene, Cinnagen.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/human-genome-sciences-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

Human Genome Sciences Inc. — Portfolio Competitive Intelligence Brief

Human Genome Sciences Inc. pipeline: 1 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 2 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Lymphostat B	BELIMUMAB	marketed	B Lymphocyte Stimulator-specific Inhibitor [EPC]	Tumor necrosis factor ligand superfamily member 13B	Oncology	2011-01-01
albumin interferon alfa-2b	albumin interferon alfa-2b	phase 3	Interferon	IFNAR	Oncology

Therapeutic area mix

Oncology · 2
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 1 shared drug class
Biogen · 1 shared drug class
Case Comprehensive Cancer Center · 1 shared drug class
Celgene · 1 shared drug class
Cinnagen · 1 shared drug class
EMD Serono · 1 shared drug class
EMD Serono Research & Development Institute, Inc. · 1 shared drug class
Active Biotech AB · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Human Genome Sciences Inc.:

Cite this brief

Drug Landscape (2026). Human Genome Sciences Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/human-genome-sciences-inc. Accessed 2026-05-15.